Assessment of the Vitamin B12 Status of Pregnant Women in Nigeria Using Plasma Holotranscobalamin
Author(s) -
Dorothy J. VanderJagt,
Innocent A. O. Ujah,
Eugene Ikeh,
Jessica M. Bryant,
Victor C. Pam,
Amelia Hilgart,
Michael Crossey,
Robert H. Glew
Publication year - 2011
Publication title -
isrn obstetrics and gynecology
Language(s) - English
Resource type - Journals
eISSN - 2090-4444
pISSN - 2090-4436
DOI - 10.5402/2011/365894
Subject(s) - vitamin b12 , medicine , second trimester , homocysteine , pregnancy , first trimester , obstetrics , neural tube , endocrinology , physiology , gestation , biology , genetics , microbiology and biotechnology , embryo
Maternal vitamin B12 deficiency during pregnancy is an independent risk factor for neural tube defects and other neurological problems in infants. We determined the vitamin B12 status of 143 pregnant women in Nigeria representing all trimesters who presented to an antenatal clinic in Jos, Nigeria, using holotranscobalamin II levels (holoTCII), which is a measure of the vitamin B12 that is available for uptake into tissues. The holoTCII concentration ranged from 13 to 128 pmol/L. Using a cutoff of 40 pmol/L, 36% of the women were classified as vitamin B12-deficient. HoloTCII concentrations correlated negatively with plasma homocysteine levels ( r = −0.24, P = 0.003) and positively with red blood cell folate concentrations ( r = 0.28, P < 0.001). These data underscore the importance of supplementing pregnant women in Nigeria with vitamin B12 in order to ensure adequate vitamin B12 status and decrease the risk for neural tube defects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom